Author name: comtex

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Hims & Hers Health, Inc. (NYSE: HIMS)

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Hims & Hers Health, Inc. (NYSE: HIMS) GlobeNewswire July 28, 2025 NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) […]

LENZ Therapeutics Announces NMPA Submission of New Drug Application for LNZ100 in China for the Treatment of Presbyopia

LENZ Therapeutics Announces NMPA Submission of New Drug Application for LNZ100 in China for the Treatment of Presbyopia Submission of NDA for LNZ100 in China by CORXEL Pharmaceuticals results in achievement of first milestone due to LENZ under the Development and Commercialization Agreement GlobeNewswire July 28, 2025 SAN DIEGO, July 28, 2025 (GLOBE NEWSWIRE) —

Smith Profits and Junior Patriots Offer St. Jude Children’s Research Hospital the Opportunity to Help Patients Become #1 Best Selling Authors

Smith Profits and Junior Patriots Offer St. Jude Children's Research Hospital the Opportunity to Help Patients Become #1 Best Selling Authors GlobeNewswire July 28, 2025 WINTER GARDEN, Fla., July 28, 2025 (GLOBE NEWSWIRE) — Smith Profits, the Winter Garden-based business consulting and publishing firm, announces a groundbreaking corporate social responsibility initiative to offer St. Jude

INVESTOR ALERT: Investigation of Barnes & Noble Education, Inc. (BNED) Announced by Holzer & Holzer, LLC

INVESTOR ALERT: Investigation of Barnes & Noble Education, Inc. (BNED) Announced by Holzer & Holzer, LLC GlobeNewswire July 28, 2025 ATLANTA, July 28, 2025 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC is investigating whether Barnes & Noble Education, Inc. (“Barnes & Noble” or the “Company”) (NYSE: BNED) complied with federal securities laws. On July 18,

Lightbridge Successfully Fabricates Nuclear Material Samples with Enriched Uranium-Zirconium Alloy for Testing in the Advanced Test Reactor

Lightbridge Successfully Fabricates Nuclear Material Samples with Enriched Uranium-Zirconium Alloy for Testing in the Advanced Test Reactor GlobeNewswire July 28, 2025 RESTON, Va., July 28, 2025 (GLOBE NEWSWIRE) — Lightbridge Corporation (Nasdaq: LTBR), a leader in advanced nuclear fuel technology, today announced the successful fabrication of coupon samples using enriched uranium-zirconium alloy, a critical step

Hyperion DeFi Purchases Additional $5 Million in HYPE for Kinetiq iHYPE Strategy

Hyperion DeFi Purchases Additional $5 Million in HYPE for Kinetiq iHYPE Strategy GlobeNewswire July 28, 2025 Increases total holdings to 1,535,772 HYPE Company to host investor webinar on Tuesday, July 29th at 2:00pm ET LAGUNA HILLS, Calif., July 28, 2025 (GLOBE NEWSWIRE) — Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), today announced

Chiesi Global Rare Diseases Spotlights the Profound Impact of Epidermolysis Bullosa in the Film “Living Between Pain and Hope” as part of “The Next Frontier,” a New Series Presented by the Biotechnology Innovation Organization

Chiesi Global Rare Diseases Spotlights the Profound Impact of Epidermolysis Bullosa in the Film “Living Between Pain and Hope” as part of “The Next Frontier,” a New Series Presented by the Biotechnology Innovation Organization GlobeNewswire July 28, 2025 BOSTON, July 28, 2025 (GLOBE NEWSWIRE) — Chiesi Global Rare Diseases (Chiesi) proudly shares its contribution to

Acumen Pharmaceuticals Presents Studies Showing the Utility of a pTau217 Assay in Screening for a Phase 2 Alzheimer’s Disease Trial and Validates Sabirnetug Oligomer-Selectivity, at the Alzheimer’s Association International Conference (AAIC) 2025

Acumen Pharmaceuticals Presents Studies Showing the Utility of a pTau217 Assay in Screening for a Phase 2 Alzheimer's Disease Trial and Validates Sabirnetug Oligomer-Selectivity, at the Alzheimer's Association International Conference (AAIC) 2025 GlobeNewswire July 28, 2025 NEWTON, Mass., July 28, 2025 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a

NFI’s MCI awarded expansion order from Metrolinx, strengthening leadership in the commuter coach market

NFI's MCI awarded expansion order from Metrolinx, strengthening leadership in the commuter coach market GlobeNewswire July 28, 2025 WINNIPEG, Manitoba, July 28, 2025 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (NFI) a leader in propulsion-agnostic bus and coach mobility solutions, subsidiary Motor Coach Industries (MCI), has secured a second order

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. (NASDAQ: CAPR)

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. (NASDAQ: CAPR) GlobeNewswire July 28, 2025 NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased

Scroll to Top